PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Biochemistry and Biophysics, School of Medicine and Dentistry, University of Rochester, Rochester, NY, USA; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA.\', \'Department of Microbiology and Immunology, University of Rochester, Rochester, NY, USA.\', \'Department of Biochemistry and Biophysics, School of Medicine and Dentistry, University of Rochester, Rochester, NY, USA; Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, USA; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA.\', \'Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, USA; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA.\', \'Department of Biochemistry and Biophysics, School of Medicine and Dentistry, University of Rochester, Rochester, NY, USA; Department of Microbiology and Immunology, University of Rochester, Rochester, NY, USA; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA. Electronic address: joshua_munger@urmc.rochester.edu.\', \'Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, USA; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA. Electronic address: isaac_harris@urmc.rochester.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0042-6822(21)00233-610.1016/j.virol.2021.11.008
?:hasPublicationType
?:journal
  • Virology
is ?:pmid of
?:pmid
?:pmid
  • 34871905
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.728
?:rankingScore_hIndex
  • 159
is ?:relation_isRelatedTo_publication of
?:title
  • Pharmacologic profiling reveals lapatinib as a novel antiviral against SARS-CoV-2 in vitro.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all